HRASLS3 Inhibitors

HRASLS3 inhibitors encompass a diverse group of compounds devised to modulate the activity or expression of the HRASLS3 protein, either directly or indirectly. These molecules, stemming from a broad chemical background, predominantly act by targeting associated signaling pathways. For instance, Staurosporine, a potent kinase inhibitor, and compounds like LY294002 and Wortmannin, which are PI3K inhibitors, exhibit the capacity to modulate cellular cascades that HRASLS3 might be implicated in.

Furthermore, BAPTA-AM and Cyclosporin A, by targeting calcium signaling, offer indirect routes to manipulate HRASLS3's cellular actions. Other inhibitors like Genistein or AG 490 emphasize the wide-reaching nature of signaling pathways in cells and how HRASLS3 might be involved in multiple cascades.